Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep 297 Frankly Speaking: Under Armour, Altius and the Biotech’s

Ep 297 Frankly Speaking: Under Armour, Altius and the Biotech’s

FromWall Street Unplugged - What's Really Moving These Markets


Ep 297 Frankly Speaking: Under Armour, Altius and the Biotech’s

FromWall Street Unplugged - What's Really Moving These Markets

ratings:
Length:
27 minutes
Released:
Mar 27, 2015
Format:
Podcast episode

Description

We start off today with a question from Tom on Under Armour. Frank’s a fan and gives you his reasons why 
Frank then covers his past recommendation on Altius. Listen today to get his current call on this natural resource royalty company and that market as a whole.
Patrick asks Frank about how many of his positions make sense to own at any one time. Should he buy everything?
And Bob as Frank if his call on biotech was premature.
And Joan writes in to say thanks for the recommendation.
Please send in your questions here. 
 
Plus, Franks brand new website is live at www.Frankcurzio.com and his new newsletter Disrupters and Dominators has launched. Go here to learn more about it.
Released:
Mar 27, 2015
Format:
Podcast episode

Titles in the series (100)

Listen to renowned small cap stock analyst Frank Curzio talk with leading economists and respected investment professionals. Frank also breaks down the news of the week so all listeners can make money in these markets!